Upgrading Right Ventricular Pacing to Cardiac Resynchronization in HFrEF Patients Improves Symptoms and Functional
Eperke Merkel1, Robert Hatala2, Mátyás Szigeti1
1Semmelweis University, Heart and Vascular Center, Budapest, Hungary.
JACC. Heart Failure
|November 30, 2024
Summary
Cardiac resynchronization therapy (CRT) upgrade significantly improved heart failure symptoms and quality of life in patients with high right ventricular pacing burden. This upgrade also reduced natriuretic peptide levels, offering benefits beyond standard device therapy.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- High right ventricular (RV) pacing burden in patients with heart failure with reduced ejection fraction (HFrEF) can lead to adverse remodeling.
- Cardiac resynchronization therapy (CRT) has shown benefits in HFrEF, but its role as an upgrade in patients with high RV pacing is less understood.
Purpose of the Study:
- To evaluate the impact of CRT upgrade on symptoms, functional status, and exercise capacity in HFrEF patients with significant RV pacing.
- To assess changes in quality of life (QoL), NYHA functional class, 6-minute walk test, and NT-proBNP levels.
Main Methods:
- The BUDAPEST-CRT Upgrade trial randomized 360 HFrEF patients with ≥20% RV pacing to either CRT with defibrillator (CRT-D) upgrade or standard ICD.
- Tertiary endpoints included changes in EQ-5D-3L for QoL, NYHA class, 6-minute walk test, and NT-proBNP levels over 12 months.
Main Results:
- CRT-D upgrade led to significant improvement in NYHA functional class compared to ICD alone (OR: 0.50; P=0.003).
- A notable reduction in NT-proBNP levels was observed in the CRT-D arm (difference: -1,257 pg/mL; P=0.017).
- CRT-D upgrade moderated the age-related decline in QoL (P-interaction=0.003), but exercise tolerance (6-minute walk test) remained unchanged.
Conclusions:
- In HFrEF patients with high RV pacing burden, CRT upgrade significantly improves functional class and reduces natriuretic peptide levels compared to ICD alone.
- CRT-D upgrade offers a potential strategy to mitigate worsening quality of life associated with aging in this patient population.
Related Concept Videos
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Mitral Regurgitation I: Introduction
4
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4
Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316


